Related references
Note: Only part of the references are listed.Burden of disease assessment in patients with neovascular age-related macular degeneration in Spain: Results of the AMD-MANAGE study
Begona Pina Marin et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)
Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration - Current Perspectives
Long T. Phan et al.
CLINICAL OPHTHALMOLOGY (2021)
Impact of Delayed Time to Treatment on Visual Outcomes in Neovascular AMD: Data From the HARBOR Study
Roger A. Goldberg et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2021)
Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset
Jordi Mones et al.
OPHTHALMOLOGICA (2020)
Prevalence of Age-Related Macular Degeneration in Europe
Johanna M. Colijn et al.
OPHTHALMOLOGY (2017)
Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration
Wataru Kikushima et al.
SCIENTIFIC REPORTS (2017)
Ranibizumab for the treatment of wet AMD: a summary of real-world studies
V. Chong
EYE (2016)
Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study
F. G. Holz et al.
EYE (2016)
Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration
Annette Rasmussen et al.
ACTA OPHTHALMOLOGICA (2015)
RELATIONSHIP BETWEEN VISUAL PROGNOSIS AND DELAY OF INTRAVITREAL INJECTION OF RANIBIZUMAB WHEN TREATING AGE-RELATED MACULAR DEGENERATION
Hidenori Takahashi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Recent developments in the treatment of age-related macular degeneration
Frank G. Holz et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
The Impact of Anti-Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration
Robert P. Finger et al.
OPHTHALMOLOGY (2014)
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al.
LANCET GLOBAL HEALTH (2014)
Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment
Sara B. Bloch et al.
ACTA OPHTHALMOLOGICA (2013)
Long-term effects of ranibizumab treatment delay in neovascular age-related macular degeneration
Philipp S. Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010
Salomon Y. Cohen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The LUMIERE Study
Salomon Y. Cohen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration
Jonathan H. Lim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
TIME TO FIRST TREATMENT The Significance of Early Treatment of Exudative Age-related Macular Degeneration
Renate Rauch et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Prevalence of age-related macular degeneration in Spain
Ricardo Casaroli-Marano et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity
Philipp Sebastian Muether et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study
R. P. Singh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
L. Arias et al.
EYE (2009)
A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
Peep V. Algvere et al.
ACTA OPHTHALMOLOGICA (2008)
The natural history and prognosis of neovascular age-related macular degeneration
Tien Wong et al.
OPHTHALMOLOGY (2008)
Ranibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR results
Peter K. Kaiser et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration
Peter K. Kaiser et al.
OPHTHALMOLOGY (2007)
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
David S. Boyer et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Age-related macular degeneration: A practical approach to a challenging disease
Dan H. Bourla et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Neovascular age-related macular degeneration - Natural history and treatment outcomes
D Pauleikhoff
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Progression of visual loss and time between initial assessment and treatment of wet age-related macular degeneration
M Oliver-Fernandez et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2005)
Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants
C Hopley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Focal inner retinal hemorrhages in patients with drusen - An early sign of occult choroidal neovascularization and chorioretinal anastomosis
JDM Gass et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
The burden of age-related macular degeneration - Results of a cohort study in two french referral centres
J Bonastre et al.
PHARMACOECONOMICS (2003)
Share Paper
